Clinical Trial to Evaluate Two Guidelines for the Administration of Ibuprofen in the Treatment of Persistent Ductus Arteriosus Eco-guided: Impact in the Intestinal Prognosis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.
Also called NCT04282941
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 180 participants
- Registry
-
NCT04282941
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Unknown status
Technical summary
Registry record NCT04282941. Randomized; double masking; primary purpose treatment. Start 2017-02-20 (actual); primary completion 2020-01-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to Evaluate Two Guidelines for the Administration of Ibuprofen in the Treatment of Persistent Ductus Arteriosus Eco-guided: Impact in the Intestinal Prognosis
- Acronym
- IBU24h-EchoG
- Condition
- Persistent Ductus Arteriosus
- Intervention (Drug)
- Ibuprofen in continuous (24 hours) iv infusion and EchoG
- Intervention (Drug)
- IV bolus Ibuprofen slow (15 minutes) and EchoG
- Lead sponsor
- Instituto de Investigación Hospital Universitario La Paz
Record details
- Record id
cardio:ct-nct04282941- Content hash
5f66547380db32282d4baa8fc67dc72ff10af2ca3e907170b6e1b91b4975abea